Learn about our rebrand Learn More
Washington, DC (January 27, 2025) – The Melanoma Research Foundation (MRF), the largest independent organization devoted to melanoma, is excited to announce the official ...
Description: Findings from this grant will shed light on 1) how stemness is sustained by modulating PI3Kδ signaling in T cells using FDA-approved drugs and 2) how transcri...
Description: While immunotherapy treatment has radically improved the outcomes of patients with advanced melanoma, around half of patients have no response. This is in part...
Description: According to the latest published statistics by the NIH, there are almost half a million individuals who are cancer survivors after having been diagnosed with ...
Description: While several medications, immune stimulating agents, and radiation therapies have been developed and used for the treatment of melanoma, the treatment options...
Description: Hybrid cells, in circulation and in the tumor are reprogrammed cancer cells displaying immune cell mimicry—insights into their impact on tumor progression, i...
Description: Background: Racial inequities in melanoma survival have been documented in the literature. The largest Black-white difference in overall cancer survival is for...
